Clinical Scorecard: International Kidney Cancer Collaboration with Leadership from Philadelphia

At a Glance

Key Highlights

• Kidney cancer cases could double by 2050 if current trends continue.
• Modifiable risk factors include obesity, diabetes, hypertension, lack of exercise, and smoking.
• The R.E.N.A.L. Nephrometry Score is a widely cited tool for assessing tumor complexity.
• The Fox Chase – Temple Urologic Institute aims to expand genetic testing and survivorship models.
• The study emphasizes the need for prevention, early detection, and policy planning.

Guideline-Based Recommendations

Diagnosis

• Utilize genetic testing to identify predispositions to kidney cancer.

Management

• Implement strategies to address modifiable risk factors.

Monitoring & Follow-up

• Establish new survivorship models reflecting projected increases in kidney cancer incidence.

Risks

• Educate providers and patients about the impact of lifestyle factors on kidney cancer risk.

Patient & Prescribing Data

Patients with risk factors for kidney cancer and those diagnosed with the disease.

Focus on minimally invasive surgery and active surveillance for small tumors.

Clinical Best Practices

• Promote early detection and prevention strategies.
• Educate patients on modifiable risk factors.
• Utilize the R.E.N.A.L. Nephrometry Score for tumor assessment.

References

• Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors